Non-obvious effects of montelukast – leukotriene receptor blocker: frigoprotective and anticonvulsant properties
The participation of arachidonic acid metabolism products – prostaglandins and leukotrienes – in the process of inflammation is a common pathogenetic link of cold injury and epilepsy. Montelukast is widely used for the treatment of bronchial asthma and allergic rhinitis as a leukotriene receptor bl...
Saved in:
Main Authors: | S.Yu. Shtrygol, I.G. Kapelka, M.V. Mishchenko, O.Ya. Mishchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Dnipro State Medical University
2021-06-01
|
Series: | Medičnì Perspektivi |
Subjects: | |
Online Access: | https://journals.uran.ua/index.php/2307-0404/article/view/234486 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 1
by: N. G. Astafieva, et al.
Published: (2024-04-01) -
Cysteine leukotrienes as key mediators of immune-dependent diseases and the therapeutic potential of the leukotriene receptor antagonist (montelukast). Part 2
by: N. G. Astafieva, et al.
Published: (2024-05-01) -
BRONCHIAL OBSTRUCTION IN CHILDREN: A NEW SOLUTION TO AN OLD PROBLEM
by: O. I. Simonova, et al.
Published: (2015-04-01) -
Determination of Montelukast Sodium by flow injection chemiluminescence
by: Omar Adnan Hashem, et al.
Published: (2023-01-01) -
COST–EFFECTIVENESS ANALYSIS OF THE MONTELUKAST APPLICATION IN CHILDREN WITH BRONCHIAL ASTHM IN THE CONDITIONS OF THE REPUBLIC OF BELARUS HEALTH CARE SYSTEM
by: I. N. Kozhanova, et al.
Published: (2012-10-01)